BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 5802998)

  • 1. [The acid and alkaline phosphatase activity in the serum of patients with prostatic cancer. The effect of endocrine therapy].
    Thijs LG; Poelman JR; Noll WL
    Ned Tijdschr Geneeskd; 1969 Jul; 113(30):1303-9. PubMed ID: 5802998
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enzymological study of prostatic cancer. II. Serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase activity and lactic dehydrogenase isoenzymes in prostatic cancer, with special reference to relation with stage and histological malignancy].
    Ishibe T; Nihira H; Mori K
    Hinyokika Kiyo; 1969 Apr; 15(4):254-65. PubMed ID: 5817349
    [No Abstract]   [Full Text] [Related]  

  • 3. [Enzymological study of prostatic cancer. V. Alterations in the serum acid and alkaline phosphatase and leucine aminopeptidase activities following massage of the prostate].
    Ishibe T
    Nihon Hinyokika Gakkai Zasshi; 1972 Oct; 63(10):873-7. PubMed ID: 4119371
    [No Abstract]   [Full Text] [Related]  

  • 4. New assays for prostatic acid phosphatase and alkaline phosphatase isoenzymes.
    Pontes JE
    Urology; 1981 Mar; 17(Suppl 3):38-9. PubMed ID: 7010753
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on glycolytic enzymes in relation to cancer. 3. Clinical significance of serum phosphohexose isomerase and aldolase in cancer of the prostate. A comparative study with serum acid phosphatase and serum alkaline phosphatase.
    Damle SR; Talavdekar RV; Panse TB
    Indian J Cancer; 1971 Sep; 8(3):176-84. PubMed ID: 5141722
    [No Abstract]   [Full Text] [Related]  

  • 6. [The prognostic significance of alkaline and acid phosphatase levels in the hormonal treatment of patients with prostatic carcinoma].
    Mulders PF; Debruyne FM
    Ned Tijdschr Geneeskd; 1987 Aug; 131(32):1399-402. PubMed ID: 3658014
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical aspects of prostatic carcinoma.
    Foo KT; Tan EC; Tung KH; Lee YS
    Singapore Med J; 1982 Oct; 23(5):269-72. PubMed ID: 7157007
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contribution on the clinical aspects of prostatic carcinoma].
    Sladczyk E
    Z Arztl Fortbild (Jena); 1967 Jul; 61(13):657-60. PubMed ID: 5598256
    [No Abstract]   [Full Text] [Related]  

  • 9. Alkaline and acid phosphatase determinations in bone disease.
    Van Lente F
    Orthop Clin North Am; 1979 Apr; 10(2):437-50. PubMed ID: 36589
    [No Abstract]   [Full Text] [Related]  

  • 10. [The determination of serum phosphatases].
    Dauchy F
    Presse Med (1893); 1968 Mar; 76(11):523-4. PubMed ID: 5646258
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prostatic cancer: indications for hormone therapy].
    Bruntsch U; Gallmeier WM
    MMW Munch Med Wochenschr; 1979 Mar; 121(9):300-2. PubMed ID: 85258
    [No Abstract]   [Full Text] [Related]  

  • 12. Histochemical and biochemical enzyme studies in prostatic carcinomatous tissue before and during treatment with estrogen.
    Nilsson T; Müntzing J
    Scand J Urol Nephrol; 1973; 7(1):14-7. PubMed ID: 4701653
    [No Abstract]   [Full Text] [Related]  

  • 13. Experience with an LHRH analogue in the management of relapsed progressive prostatic cancer.
    Kerle D; Williams G; Ware H; Doble A; Allen J; Bloom SR
    Br J Urol; 1984 Oct; 56(5):495-8. PubMed ID: 6242022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II evaluation of weekly cisplatin in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group Trial.
    Moore MR; Troner MB; DeSimone P; Birch R; Irwin L
    Cancer Treat Rep; 1986 Apr; 70(4):541-2. PubMed ID: 3698053
    [No Abstract]   [Full Text] [Related]  

  • 15. [Importance of serum acid phosphatase for the prognosis of prostatic carcinoma].
    Breitwieser P; Nöske HD
    Z Urol Nephrol; 1971 Apr; 64(4):249-56. PubMed ID: 5094006
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of advanced prostatic carcinoma with medroxyprogesterone.
    Rafla S; Johnson R
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):261-7. PubMed ID: 4208339
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of the prostatic massage on the activity of acid serum phosphatase in prostatic carcinoma].
    Ziesche HW
    Z Urol Nephrol; 1967 Aug; 60(8):529-34. PubMed ID: 5586587
    [No Abstract]   [Full Text] [Related]  

  • 18. Occult carcinoma of the prostate.
    El-Morsi AR
    J Egypt Med Assoc; 1974; 57(7-8):373-7. PubMed ID: 4452775
    [No Abstract]   [Full Text] [Related]  

  • 19. [Phosphatases and bone scan in prostatic cancer].
    Urrutia M; Montero J; Grade J; Llopis M
    Actas Urol Esp; 1977; 1(4):207-12. PubMed ID: 567001
    [No Abstract]   [Full Text] [Related]  

  • 20. [Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].
    Gaca A; Panitz N
    Helv Chir Acta; 1981 Aug; 48(3-4):465-6. PubMed ID: 7287485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.